Predicting the risk of interval distant metastases in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy-Reference-Cited by-同舟云学术

Predicting the risk of interval distant metastases in patients with esophageal squamous cell carcinoma undergoing chemoradiotherapy

Published:2022-02 Issue:2 Volume:121 Page:539-545
ISSN:0929-6646
Container-title:Journal of the Formosan Medical Association
language:en
Short-container-title:Journal of the Formosan Medical Association

Author:

Lin Yong-Jhih,Chang Yu-Chuan,Wen Yu-Wen,Chan Sheng-Chieh,Chao Yin-Kai

Publisher

Elsevier BV

Subject

General Medicine

Reference21 articles.

1. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis;Sjoquist;Lancet Oncol,2011

2. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015

3. Definitive chemoradiotherapy versus trimodality therapy for resectable oesophageal carcinoma: meta-analyses and systematic review of literature;Voeten;World J Surg,2019

4. Restaging oesophageal cancer after neoadjuvant therapy with 18F-FDG PET-CT: identifying interval metastases and predicting incurable disease at surgery;Findlay;Eur Radiol,2016

5. Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18 F-FDG PET/CT;Goense;Eur J Nucl Med Mol Imag,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A population-based investigation: How to identify high-risk T1-2N0 esophageal cancer patients?;Frontiers in Surgery;2023-01-17

2. The risk and prognostic factors for liver metastases in esophageal cancer patients: A large‐cohort based study;Thoracic Cancer;2022-09-28

3. Highlights;Journal of the Formosan Medical Association;2022-02